Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Receivables - Other (2010 - 2025)

Updated

Sinovac Biotech (SVA) reported Receivables - Other of $20.4 million for Q4 2025, up 5.4% from $19.35 million a year earlier.

Analysis

Sinovac Biotech (SVA) Receivables - Other (2010 - 2025) Analysis & Trends

Dating back to Q4 2010, Sinovac Biotech's Receivables - Other record includes 6 quarters.

  • Receivables - Other has a four-year compound annual growth rate of -9.9% (FY2021 to FY2025).
  • By year, Receivables - Other came in at $19.35 million in FY2024 (-14.6%), $22.65 million in FY2023 (-27.0%), $31.02 million in FY2022 (+0.1%) and $30.98 million in FY2021.
  • The Q4 2025 figure ranks as the highest quarterly Receivables - Other since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.40 Mn
Dec 31, 2024 19.35 Mn
Dec 31, 2023 22.65 Mn
Dec 31, 2022 31.02 Mn
Dec 31, 2021 30.98 Mn
Dec 31, 2010 3.40 Mn
API Access

Sinovac Biotech Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SVA&period=max&api_key=YOUR_API_KEY